


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
HP
Helmerich & Payne
$26.74
Latest Comments
Yesterday at 12:28
Strengths

Upgraded on attractively valued
Chart
$25.32 (+5.61%)
$20.89 (+28.00%)
$16.42 (+62.85%)
$34.45 (-22.38%)
HP has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

HP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
HP Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HP Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is HP current stock price?
What are HP stock strengths?
What is HP Risk Level?
What is HP market cap and volume?
What is HP current Stock IQ?
Should I buy HP stock right now?
Is HP a Strong Buy right now?
What does a 'Strong Buy' rating mean for HP?
What does a 'Strong Sell' rating mean for HP?
What factors influence HP's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
HP
Helmerich & Payne
Current Price
$26.74
Stock Insights
Strengths

Upgraded on attractively valued

Yesterday at 12:28
Chart
$25.32 (+5.61%)
$20.89 (+28.00%)
$16.42 (+62.85%)
$34.45 (-22.38%)
HP Analysts Opinion
HP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
HP Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HP Street Sentiment is bullish and have positive views on the near-term outlook
HP has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
HP Latest Analysis
Goldman Sachs Upgrades Helmerich & Payne (HP). Fintel reports that on November 21 2025 Goldman Sachs upgraded their outlook for Helmerich &. Payne (NYSE:HP) from Sell to Neutral. Analyst Price Forecast Suggests 6.21% Downside
Fri Nov 21, 2025
Barclays Maintains Helmerich & Payne (HP) Overweight Recommendation. Fintel reports that on November 20 2025 Barclays maintained coverage of Helmerich &. Payne (NYSE:HP) with a Overweight recommendation. Analyst Price Forecast Suggests 6.17% Downside
Fri Nov 21, 2025
Evercore ISI Group Maintains Helmerich & Payne (HP) In-Line Recommendation. Fintel reports that on November 19 2025 Evercore ISI Group maintained coverage of Helmerich &. Payne (NYSE:HP) with a In-Line recommendation. Analyst Price Forecast Suggests 10.02% Downside
Thu Nov 20, 2025
Susquehanna Maintains Helmerich & Payne (HP) Positive Recommendation. Fintel reports that on November 19 2025 Susquehanna maintained coverage of Helmerich &. Payne (NYSE:HP) with a Positive recommendation. Analyst Price Forecast Suggests 7.83% Downside
Wed Nov 19, 2025
Helmerich & Payne (HP) Reports Q4 Loss Beats Revenue Estimates. Helmerich & Payne (HP) delivered earnings and revenue surprises of -103.85% and 3.70% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Mon Nov 17, 2025
Ex-Div Reminder for Helmerich & Payne (HP). Looking at the universe of stocks we cover at Dividend Channel on 11/18/25 Helmerich &. Payne Inc. (Symbol: HP) will trade ex-dividend for its quarterly dividend of $0.25 payable on 12/2/25. As a percentage of HPs recent stock price of $26.98 this dividend works out t
Fri Nov 14, 2025
Seeking Clues to Helmerich & Payne (HP) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics. Beyond analysts top-and-bottom-line estimates for Helmerich & Payne (HP) evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Thu Nov 13, 2025
Analysts Estimate Helmerich & Payne (HP) to Report a Decline in Earnings: What to Look Out for. Helmerich & Payne (HP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mon Nov 10, 2025
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights. Reported positive topline results from the Phase 2 Avail™ trial of once-weekly canvuparatide in hypoparathyroidism (HP)
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.